|
|
Updated Wednesday, January 11, 2012 0:12 am TWN, AP |
| ||||||||||||
Next Amgen chief sees more markets, higher sales thanks to new productsChief Operating Officer Robert A. Bradway is to succeed current Chief Executive Kevin Sharer this May as head of the world's largest biotech company. Bradway told analysts that the Thousand Oaks, California, company's performance was “solid across the board” last year. He said he believes cash flow and earnings per share will rise this year and said Amgen will continue buying back its stock. Bradway also said positive results from six mid- or late-stage studies expected over the next five years could lead to higher sales in the future. Bradway, who will be Amgen's fourth CEO, spoke Monday at the 30th Annual J.P. Morgan Global Healthcare Conference in San Francisco. “2011 was a solid year, but I'm even more confident about the outlook for 2012,” Bradway said. | |||||||||||||